Trace amine-associated receptor 1 (TAAR1) agonism as a new treatment strategy for schizophrenia and related disorders
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Trace amine-associated receptor 1 (TAAR1) agonism as a new treatment strategy for schizophrenia and related disorders
Authors
Keywords
-
Journal
TRENDS IN NEUROSCIENCES
Volume 46, Issue 1, Pages 60-74
Publisher
Elsevier BV
Online
2022-11-08
DOI
10.1016/j.tins.2022.10.010
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Immunoelectron Microscopy of Trace Amine‐Associate Receptor 1 Intracellular Localization
- (2022) Julia Huey et al. FASEB JOURNAL
- Integrating the neurodevelopmental and dopamine hypotheses of schizophrenia and the role of cortical excitation-inhibition balance.
- (2022) Oliver D. Howes et al. BIOLOGICAL PSYCHIATRY
- Interaction analyses of hTAAR1 and mTAAR1 with antagonist EPPTB
- (2022) Siyan Liao et al. LIFE SCIENCES
- Safety and Effectiveness of SEP−363856 in Schizophrenia: Results of a 6-Month, Open-Label Extension Study
- (2021) Christoph U. Correll et al. CNS SPECTRUMS
- Beyond Dopamine Receptor Antagonism: New Targets for Schizophrenia Treatment and Prevention
- (2021) Felipe V. Gomes et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Role of trace amine‑associated receptor 1 in the medial prefrontal cortex in chronic social stress-induced cognitive deficits in mice
- (2021) Yue Zhang et al. PHARMACOLOGICAL RESEARCH
- Trace Amine-Associated Receptor 1 Contributes to Diverse Functional Actions of O-Phenyl-Iodotyramine in Mice but Not to the Effects of Monoamine-Based Antidepressants
- (2021) Ioannis Mantas et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Binding of SEP-363856 within TAAR1 and the 5HT1A receptor: implications for the design of novel antipsychotic drugs
- (2021) Pramod C. Nair et al. MOLECULAR PSYCHIATRY
- N-methyl-D-aspartate receptor availability in first-episode psychosis: a PET-MR brain imaging study
- (2021) Katherine Beck et al. Translational Psychiatry
- Therapeutic Potential of TAAR1 Agonists in Schizophrenia: Evidence from Preclinical Models and Clinical Studies
- (2021) Nina Dedic et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- New and emerging treatments for schizophrenia: a narrative review of their pharmacology, efficacy and side effect profile relative to established antipsychotics
- (2021) Maria C. Lobo et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Ulotaront: A TAAR1 Agonist for the Treatment of Schizophrenia
- (2021) Michele L. R. Heffernan et al. ACS Medicinal Chemistry Letters
- Dopamine and glutamate in schizophrenia: biology, symptoms and treatment
- (2020) Robert A. McCutcheon et al. World Psychiatry
- Reproducing the dopamine pathophysiology of schizophrenia and approaches to ameliorate it: a translational imaging study with ketamine
- (2020) Michelle Kokkinou et al. MOLECULAR PSYCHIATRY
- A Non–D2-Receptor-Binding Drug for the Treatment of Schizophrenia
- (2020) Kenneth S. Koblan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Transcriptional and imaging-genetic association of cortical interneurons, brain function, and schizophrenia risk
- (2020) Kevin M. Anderson et al. Nature Communications
- Trace Amine-Associated Receptor 1 (TAAR1): A new drug target for psychiatry?
- (2020) Seetal Dodd et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- TAAR1 dependent and independent actions of tyramine in interaction with glutamate underlie central effects of monoamine oxidase inhibition
- (2020) Ioannis Mantas et al. BIOLOGICAL PSYCHIATRY
- A Systematic Review of the Symptom Profile and Course of Methamphetamine-Associated Psychosis
- (2019) Alexandra Voce et al. SUBSTANCE USE & MISUSE
- Tyrosine hydroxylase phosphorylation in vivo
- (2019) Peter R. Dunkley et al. JOURNAL OF NEUROCHEMISTRY
- Trace Amine-Associated Receptor 1 Agonist Modulates Mismatch Negativity-Like Responses in Mice
- (2019) Aleksander A. Aleksandrov et al. Frontiers in Pharmacology
- SEP-363856, A NOVEL PSYCHOTROPIC AGENT WITH A UNIQUE, NON-D2 RECEPTOR MECHANISM OF ACTION
- (2019) Nina Dedic et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Antipsychotics: Mechanisms underlying clinical response and side-effects and novel treatment approaches based on pathophysiology
- (2019) Stephen J. Kaar et al. NEUROPHARMACOLOGY
- Amphetamines signal through intracellular TAAR1 receptors coupled to Gα13 and GαS in discrete subcellular domains
- (2019) Suzanne M. Underhill et al. MOLECULAR PSYCHIATRY
- Non-Functional Trace Amine-Associated Receptor 1 Variants in Patients With Mental Disorders
- (2019) Grazia Rutigliano et al. Frontiers in Pharmacology
- The Action of TAAR1 Agonist RO5263397 on Executive Functions in Rats
- (2019) Artem Dorotenko et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- Molecular Variants in Human Trace Amine-Associated Receptors and Their Implications in Mental and Metabolic Disorders
- (2019) Grazia Rutigliano et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- Effect of trace amine-associated receptor 1 agonist RO5263397 on sensory gating in mice
- (2019) Aleksander A. Aleksandrov et al. NEUROREPORT
- Schizophrenia—An Overview
- (2019) Robert A. McCutcheon et al. JAMA Psychiatry
- TAAR Agonists
- (2019) Zhengrong Xu et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- Dopamine Evokes a Trace Amine Receptor-dependent Inward Current that is Regulated by AMP Kinase in Substantia Nigra Dopamine Neurons
- (2019) Wei Yang et al. NEUROSCIENCE
- The effects of antipsychotic treatment on presynaptic dopamine synthesis capacity in first episode psychosis: a positron emission tomography study.
- (2018) Sameer Jauhar et al. BIOLOGICAL PSYCHIATRY
- Rational design, chemical synthesis and biological evaluation of novel biguanides exploring species-specificity responsiveness of TAAR1 agonists
- (2018) Sara Guariento et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Determinants of treatment response in first-episode psychosis: an 18F-DOPA PET study
- (2018) Sameer Jauhar et al. MOLECULAR PSYCHIATRY
- Trace Amines and Their Receptors
- (2018) Raul R. Gainetdinov et al. PHARMACOLOGICAL REVIEWS
- The Case for TAAR1 as a Modulator of Central Nervous System Function
- (2018) Grazia Rutigliano et al. Frontiers in Pharmacology
- Striatal Tyrosine Hydroxylase Is Stimulated via TAAR1 by 3-Iodothyronamine, But Not by Tyramine or β-Phenylethylamine
- (2018) Xiaoqun Zhang et al. Frontiers in Pharmacology
- Biochemical and Functional Characterization of the Trace Amine-Associated Receptor 1 (TAAR1) Agonist RO5263397
- (2018) Stefano Espinoza et al. Frontiers in Pharmacology
- Targeting GSK3 signaling as a potential therapy of neurodegenerative diseases and aging
- (2018) Przemysław Duda et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Novel biguanide-based derivatives scouted as TAAR1 agonists: Synthesis, biological evaluation, ADME prediction and molecular docking studies
- (2017) Michele Tonelli et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Dopamine induces glutamate accumulation in astrocytes to disrupt neuronal function leading to pathogenesis of minimal hepatic encephalopathy
- (2017) Saidan Ding et al. NEUROSCIENCE
- Pharmacology of human trace amine-associated receptors: Therapeutic opportunities and challenges
- (2017) Mark D. Berry et al. PHARMACOLOGY & THERAPEUTICS
- Antipsychotic treatment resistance in first-episode psychosis: prevalence, subtypes and predictors
- (2017) A. Demjaha et al. PSYCHOLOGICAL MEDICINE
- Defining the Locus of Dopaminergic Dysfunction in Schizophrenia: A Meta-analysis and Test of the Mesolimbic Hypothesis
- (2017) Robert McCutcheon et al. SCHIZOPHRENIA BULLETIN
- Possible role of rare variants in Trace amine associated receptor 1 in schizophrenia
- (2017) Jibin John et al. SCHIZOPHRENIA RESEARCH
- Interaction Between the Trace Amine-Associated Receptor 1 and the Dopamine D2 Receptor Controls Cocaine’s Neurochemical Actions
- (2017) Aman Asif-Malik et al. Scientific Reports
- A Test of the Transdiagnostic Dopamine Hypothesis of Psychosis Using Positron Emission Tomographic Imaging in Bipolar Affective Disorder and Schizophrenia
- (2017) Sameer Jauhar et al. JAMA Psychiatry
- Investigation of Naturally Occurring Single-Nucleotide Variants in Human TAAR1
- (2017) Jessica Mühlhaus et al. Frontiers in Pharmacology
- Increased context-dependent conditioning to amphetamine in mice lacking TAAR1
- (2016) Ilya Sukhanov et al. PHARMACOLOGICAL RESEARCH
- Two distinct patterns of treatment resistance: clinical predictors of treatment resistance in first-episode schizophrenia spectrum psychoses
- (2016) J. Lally et al. PSYCHOLOGICAL MEDICINE
- Nature of Glutamate Alterations in Schizophrenia
- (2016) Kate Merritt et al. JAMA Psychiatry
- Pharmacological characterization of a high-affinity p-tyramine transporter in rat brain synaptosomes
- (2016) Mark D. Berry et al. Scientific Reports
- Trace amine-associated receptor 1 activation silences GSK3β signaling of TAAR1 and D2R heteromers
- (2015) Anja Harmeier et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Glutamate and dopamine in schizophrenia: An update for the 21st century
- (2015) Oliver Howes et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Postsynaptic D2 dopamine receptor supersensitivity in the striatum of mice lacking TAAR1
- (2015) Stefano Espinoza et al. NEUROPHARMACOLOGY
- TAAR1 Modulates Cortical Glutamate NMDA Receptor Function
- (2015) Stefano Espinoza et al. NEUROPSYCHOPHARMACOLOGY
- Deficits in Prefrontal Cortical and Extrastriatal Dopamine Release in Schizophrenia
- (2015) Mark Slifstein et al. JAMA Psychiatry
- The glutamate hypothesis of schizophrenia: evidence from human brain tissue studies
- (2014) Wei Hu et al. Annals of the New York Academy of Sciences
- Methamphetamine and HIV-1-induced neurotoxicity: Role of trace amine associated receptor 1 cAMP signaling in astrocytes
- (2014) Irma E. Cisneros et al. NEUROPHARMACOLOGY
- Taar1-mediated modulation of presynaptic dopaminergic neurotransmission: Role of D2 dopamine autoreceptors
- (2014) D. Leo et al. NEUROPHARMACOLOGY
- Alterations in the serotonin system in schizophrenia: A systematic review and meta-analysis of postmortem and molecular imaging studies
- (2014) Sudhakar Selvaraj et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Presynaptic Striatal Dopamine Dysfunction in People at Ultra-high Risk for Psychosis: Findings in a Second Cohort
- (2013) Alice Egerton et al. BIOLOGICAL PSYCHIATRY
- Developmental Pattern of Perineuronal Nets in the Human Prefrontal Cortex and Their Deficit in Schizophrenia
- (2013) Sarah A. Mauney et al. BIOLOGICAL PSYCHIATRY
- Amphetamine Mechanisms and Actions at the Dopamine Terminal Revisited
- (2013) E. S. Calipari et al. JOURNAL OF NEUROSCIENCE
- The Nature of Dopamine Dysfunction in Schizophrenia and What This Means for Treatment
- (2012) Oliver D. Howes et al. ARCHIVES OF GENERAL PSYCHIATRY
- Trace Amine-Associated Receptor 1 Partial Agonism Reveals Novel Paradigm for Neuropsychiatric Therapeutics
- (2012) Florent G. Revel et al. BIOLOGICAL PSYCHIATRY
- A new perspective for schizophrenia: TAAR1 agonists reveal antipsychotic- and antidepressant-like activity, improve cognition and control body weight
- (2012) F G Revel et al. MOLECULAR PSYCHIATRY
- Brain-Specific Overexpression of Trace Amine-Associated Receptor 1 Alters Monoaminergic Neurotransmission and Decreases Sensitivity to Amphetamine
- (2012) Florent G Revel et al. NEUROPSYCHOPHARMACOLOGY
- Dichotomy of Tyrosine Hydroxylase and Dopamine Regulation between Somatodendritic and Terminal Field Areas of Nigrostriatal and Mesoaccumbens Pathways
- (2012) Michael F. Salvatore et al. PLoS One
- Behavioral effects of clozapine: Involvement of trace amine pathways in C. elegans and M. musculus
- (2011) Rakesh Karmacharya et al. BRAIN RESEARCH
- Animal models of schizophrenia
- (2011) CA Jones et al. BRITISH JOURNAL OF PHARMACOLOGY
- Genetic Deletion of Trace Amine 1 Receptors Reveals Their Role in Auto-Inhibiting the Actions of Ecstasy (MDMA)
- (2011) B. Di Cara et al. JOURNAL OF NEUROSCIENCE
- Functional Interaction between Trace Amine-Associated Receptor 1 and Dopamine D2 Receptor
- (2011) S. Espinoza et al. MOLECULAR PHARMACOLOGY
- Augmentation of methamphetamine-induced behaviors in transgenic mice lacking the trace amine-associated receptor 1
- (2011) Cindy Achat-Mendes et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activity
- (2011) F. G. Revel et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Increased Synaptic Dopamine Function in Associative Regions of the Striatum in Schizophrenia
- (2010) Lawrence S. Kegeles et al. ARCHIVES OF GENERAL PSYCHIATRY
- Extracellular Matrix-Glial Abnormalities in the Amygdala and Entorhinal Cortex of Subjects Diagnosed With Schizophrenia
- (2010) Harry Pantazopoulos et al. ARCHIVES OF GENERAL PSYCHIATRY
- Correction: The Dopamine Metabolite 3-Methoxytyramine Is a Neuromodulator
- (2010) Tatyana D. Sotnikova et al. PLoS One
- The selective antagonist EPPTB reveals TAAR1-mediated regulatory mechanisms in dopaminergic neurons of the mesolimbic system
- (2009) A. Bradaia et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Akt/GSK3 Signaling in the Action of Psychotropic Drugs
- (2008) Jean-Martin Beaulieu et al. Annual Review of Pharmacology and Toxicology
- Modulation of Monoamine Transporters by Common Biogenic Amines via Trace Amine-Associated Receptor 1 and Monoamine Autoreceptors in Human Embryonic Kidney 293 Cells and Brain Synaptosomes
- (2008) Z. Xie et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- -Phenylethylamine Alters Monoamine Transporter Function via Trace Amine-Associated Receptor 1: Implication for Modulatory Roles of Trace Amines in Brain
- (2008) Z. Xie et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started